Skip to main content
Published locations for Pembrolizumab-axitinib nearly halves risk of death in RCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Pembrolizumab-axitinib nearly halves risk of death in RCC
User login
Username
Password
Reset your password
/content/pembrolizumab-axitinib-nearly-halves-risk-death-rcc
/oncologypractice/article/194359/renal-cell-carcinoma/pembrolizumab-axitinib-nearly-halves-risk-death
/hematology-oncology/article/194359/renal-cell-carcinoma/pembrolizumab-axitinib-nearly-halves-risk